Stelara for chronic moderate to severe psoriasis

Canadians will be the first to be able to try Stelara for chronic moderate to severe psoriasis.

Stelara (ustekinumab) is a human monoclonal antibody.

It works by blocking interleukin IL-12 and IL-23. Most other biologics for psoriasis (Enbrel, Remicade, Humira) work differently. They block tumour necrosis factor.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote